Additional file 1 of First effectiveness data of lenvatinib and pembrolizumab as first-line therapy in advanced anaplastic thyroid cancer: a retrospective cohort study
posted on 2024-02-22, 04:42authored byDominik Soll, Philip Bischoff, Anne Frisch, Marie Jensen, Zehra Karadeniz, Martina T. Mogl, David Horst, Tobias Penzkofer, Joachim Spranger, Ulrich Keilholz, Knut Mai